Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation

Cellular and Molecular Life Sciences

Volumn 71, Issue 7, 2014, Pages 1305-1314

  Knoblich, Konstantin ^a   Wang, Hong Xing ^a   Sharma, Chandan ^a   Fletcher, Anne L ^a,b   Turley, Shannon J ^a   Hemler, Martin E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Tetraspanin; TSPAN12; Tumor growth; Tumor metastasis; catenin

Indexed keywords

ATAXIN 1; BETA CATENIN; DISHEVELLED 2; DVL3 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; NAKED 1 PROTEIN; PROTEIN TSPAN12; REGULATOR PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; FRIZZLED PROTEIN; FZD4 PROTEIN, HUMAN; LRP5 PROTEIN, HUMAN; TETRASPANIN; TSPAN12 PROTEIN, HUMAN; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCNA1 GENE; CCNE2 GENE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; ID4 GENE; ME1 GENE; METASTASIS; MOUSE; NONHUMAN; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SFN GENE; TUMOR GENE; TUMOR GROWTH; WISP1 GENE; WNT SIGNALING PATHWAY; ANIMAL; APOPTOSIS; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; APOPTOSIS; BETA CATENIN; BREAST NEOPLASMS; FEMALE; FRIZZLED RECEPTORS; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MICE; MICE, SCID; NEOPLASM METASTASIS; TETRASPANINS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84902117713     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1444-8     Document Type: Article

References (46)

1. Garcia-Espana A, Chung PJ, Sarkar IN, Stiner E, Sun TT, Desalle R (2008) Appearance of new tetraspanin genes during vertebrate evolution. Genomics 91:326-334
2. Poulter JA, Ali M, Gilmour DF, Rice A, Kondo H, Hayashi K, Mackey DA, Kearns LS, Ruddle JB, Craig JE, Pierce EA, Downey LM, Mohamed MD, Markham AF, Inglehearn CF, Toomes C (2010) Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. Am J Hum Genet 86:248-253
3. Nikopoulos K, Gilissen C, Hoischen A, van Nouhuys CE, Boonstra FN, Blokland EA, Arts P, Wieskamp N, Strom TM, Ayuso C, Tilanus MA, Bouwhuis S, Mukhopadhyay A, Scheffer H, Hoefsloot LH, Veltman JA, Cremers FP, Collin RW (2010) Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. Am J Hum Genet 86:240-247
4. Junge HJ, Yang S, Burton JB, Paes K, Shu X, French DM, Costa M, Rice DS, Ye W (2009) TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling. Cell 139:299-311
5. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469-480
6. Valenta T, Hausmann G, Basler K (2012) The many faces and functions of beta-catenin. EMBO J 31:2714-2736
7. Crawford HC, Dempsey PJ, Brown G, Adam L, Moss ML (2009) ADAM10 as a therapeutic target for cancer and inflammation. Curr Pharm Des 15:2288-2299
8. Xu D, Sharma C, Hemler ME (2009) Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J 23:3674-3681
9. Lara H, Wang Y, Beltran AS, Juarez-Moreno K, Yuan X, Kato S, Leisewitz AV, Cuello FM, Licea AF, Connolly DC, Huang L, Blancafort P (2012) Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors. J Biol Chem 287:29873-29886
10. Wachi S, Yoneda K, Wu R (2005) Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 21:4205-4208
11. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356:217-226
12. Casey T, Bond J, Tighe S, Hunter T, Lintault L, Patel O, Eneman J, Crocker A, White J, Tessitore J, Stanley M, Harlow S, Weaver D, Muss H, Plaut K (2009) Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res Treat 114:47-62
13. Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, Sato S, Miyauchi M, Takata T (2004) Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 10:5455-5463
14. Creighton CJ, Bromberg-White JL, Misek DE, Monsma DJ, Brichory F, Kuick R, Giordano TJ, Gao W, Omenn GS, Webb CP, Hanash SM (2005) Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation. Mol Cancer Res 3:119-129
15. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP (2006) GenePattern 2.0. Nat Genet 38:500-501
16. Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, Mohammed S, Heck AJ, Maurice MM, Mahmoudi T, Clevers H (2012) Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 149:1245-1256
17. Rousset R, Mack JA, Wharton KA Jr, Axelrod JD, Cadigan KM, Fish MP, Nusse R, Scott MP (2001) Naked cuticle targets dishevelled to antagonize Wnt signal transduction. Genes Dev 15:658-671
18. Wharton KA Jr, Zimmermann G, Rousset R, Scott MP (2001) Vertebrate proteins related to Drosophila Naked Cuticle bind Dishevelled and antagonize Wnt signaling. Dev Biol 234:93-106
19. Yasmeen A, Berdel WE, Serve H, Muller-Tidow C (2003) E- and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Rev Mol Diagn 3:617-633
20. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ (2000) WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev 14:585-595
21. Perathoner A, Pirkebner D, Brandacher G, Spizzo G, Stadlmann S, Obrist P, Margreiter R, Amberger A (2005) 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clin Cancer Res 11:3274-3279
22. Lasorella A, Uo T, Iavarone A (2001) Id proteins at the cross-road of development and cancer. Oncogene 20:8326-8333
23. Jiang P, Du W, Mancuso A, Wellen KE, Yang X (2013) Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 493:689-693
24. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, Kurup S, Glass DA, Patel MS, Shu W, Morrisey EE, McMahon AP, Karsenty G, Lang RA (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437:417-421
25. Ji P, Baumer N, Yin T, Diederichs S, Zhang F, Beger C, Welte K, Fulda S, Berdel WE, Serve H, Muller-Tidow C (2007) DNA damage response involves modulation of Ku70 and Rb functions by cyclin A1 in leukemia cells. Int J Cancer 121:706-713
26. Wegiel B, Bjartell A, Culig Z, Persson JL (2008) Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer 122:1521-1529
27. Maiese K, Chong ZZ, Shang YC, Wang S (2012) Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets 16:1203-1214
28. Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE (2009) WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 11:R32
29. Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, Di BA, Daniele B, Parente D, Colantuoni V (2010) Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer. Hum Pathol 41:867-876
30. Soon LL, Yie TA, Shvarts A, Levine AJ, Su F, Tchou-Wong KM (2003) Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem 278:11465-11470
31. Umetani N, Mori T, Koyanagi K, Shinozaki M, Kim J, Giuliano AE, Hoon DS (2005) Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer. Oncogene 24:4721-4727
32. Ikushima H, Miyazono K (2010) TGFbeta signaling: a complex web in cancer progression. Nat Rev Cancer 10:415-424
33. Kouprina N, Mullokandov M, Rogozin IB, Collins NK, Solomon G, Otstot J, Risinger JI, Koonin EV, Barrett JC, Larionov V (2004) The SPANX gene family of cancer/testis-specific antigens: rapid evolution and amplification in African great apes and hominids. Proc Natl Acad Sci USA 101:3077-3082
34. Mitamura T, Iwamoto R, Umata T, Yomo T, Urabe I, Tsuneoka M, Mekada E (1992) The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from Vero Cells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells. J Cell Biol 118:1389-1399
35. Feigelson SW, Grabovsky V, Shamri R, Levy S, Alon R (2003) The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to vascular cell adhesion molecule 1 (VCAM-1) under shear flow. J Biol Chem 278:51203-51212
36. Moribe H, Konakawa R, Koga D, Ushiki T, Nakamura K, Mekada E (2012) Tetraspanin is required for generation of reactive oxygen species by the dual oxidase system in Caenorhabditis elegans. PLoS Genet 8:e1002957
37. Sadej R, Romanska H, Baldwin G, Gkirtzimanaki K, Novitskaya V, Filer AD, Krcova Z, Kusinska R, Ehrmann J, Buckley CD, Kordek R, Potemski P, Eliopoulos AG, Lalani E, Berditchevski F (2009) CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol Cancer Res 7:787-798
38. Yang XH, Richardson AL, Torres-Arzayus MI, Zhou P, Sharma C, Kazarov AR, Andzelm MM, Strominger JL, Brown M, Hemler ME (2008) CD151 accelerates breast cancer by regulating a6 integrin functions, signaling, and molecular organization. Cancer Res 68:3204-3213
39. Li Q, Yang XH, Xu F, Sharma C, Wang HX, Knoblich K, Rabinovitz I, Granter SR, Hemler ME (2013) Tetraspanin CD151 plays a key role in skin squamous cell carcinoma. Oncogene 32:1772-1783
40. Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, Erfani SF, Sharma C, Zhou P, Rabinovitz I, Sonnenberg A, Yi A, Zhou P, Stipp CS, Kaetzel DM, Hemler ME, Yang HY (2012) Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. Neoplasia 14:678-689
41. Kazarov AR, Yang X, Stipp CS, Sehgal B, Hemler ME (2002) An extracellular site on tetraspanin CD151 determines a3 and a6 integrin-dependent cellular morphology. J Cell Biol 158:1299-1309
42. Miranti CK (2009) Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis. Cell Signal 21:196-211
43. Miyake M, Inufusa H, Adachi M, Ishida H, Hashida H, Tokuhara T, Kakehi Y (2000) Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery. Oncogene 19:5221-5226
44. Chigita S, Sugiura T, Abe M, Kobayashi Y, Shimoda M, Onoda M, Shirasuna K (2012) CD82 inhibits canonical Wnt signaling by controlling the cellular distribution of beta-catenin in carcinoma cells. Int J Oncol 41:2021-2028
45. Huang CL, Liu D, Masuya D, Kameyama K, Nakashima T, Yokomise H, Ueno M, Miyake M (2004) MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene 23:7475-7483
46. Wong SY, Haack H, Kissil JL, Barry M, Bronson RT, Shen SS, Whittaker CA, Crowley D, Hynes RO (2007) Protein 4.1B suppresses prostate cancer progression and metastasis. Proc Natl Acad Sci USA 104:12784-12789